Poland· PL-100036584

Laktomag B6

A magnesium aspartate product containing magnesii hydrogenoaspartas + pyridoxini hydrochloridum, registered in Poland by Zakład Farmaceutyczny "Amara" Sp. z o.o.. The same ATC class is registered in 7 of our 19 countries.

ATC A12CC05

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLaktomag B6ATCA12CC05REGISTER NO.PL-100036584PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Magnesium aspartate is registered in 7 of 19 countries.

Countries holding a registration under ATC A12CC05 (magnesium aspartate), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 3 of them publish a price we can compare per daily dose

Magnesium aspartate · ATC A12CC05

7 / 19 countries

  • Belgiumprice
  • Germany
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Magnesii hydrogenoaspartas + Pyridoxini hydrochloridum
Manufacturer
Zakład Farmaceutyczny "Amara" Sp. z o.o.
Country
Poland (PL)
ATC code
A12CC05
ATC class
Magnesium aspartate
Defined daily dose
10 mmol, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990357710

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

13 interactions on record for magnesium aspartate.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Magnesium aspartate · interactions on record

13 records

13 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/eacc01ad-58e1-4d80-8fea-578b258ee103
GET /v1/drugs/eacc01ad-58e1-4d80-8fea-578b258ee103?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "1000 mg (70 mg jonów magnezu) + 5 mg",
  "packaging": "05909990357710 ¦ OTC ¦ 47218\n50 tabl.",
  "substance": "Magnesii hydrogenoaspartas 1000 mg + Pyridoxini hydrochloridum (Vitaminum B6) 5 mg",
  "common_name": "Magnesii hydrogenoaspartas + Pyridoxini hydrochloridum",
  "pl_product_id": "100036584",
  "pozwolenie_nr": "03577",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about magnesium aspartate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.